Jane Gross is a highly experienced biotech executive with over 30 years of experience in immunology. As a former VP at ZymoGenetics, she has a proven track record of advancing therapeutics for autoimmune diseases and cancer. She earned her Ph. D. in Immunology from the University of California, Berkeley.
While specific personal hobbies are not publicly available, she has a clear and enduring connection to her academic origins. Her background includes a Ph. D. from UC Berkeley and a post-doctoral fellowship at the University of Washington, suggesting a deep appreciation for academic research and scientific communities.
While at ZymoGenetics, she discovered and developed over 30 new product candidates, and was instrumental in positioning the company for its acquisition by Bristol Myers Squibb.
Jane Gross
Vice President, Research Immunology at ZymoGenetics Inc.
Seattle, Washington, United States
Overview
Topics They Care About
Drug Development
She has extensive experience leading teams through the entire therapeutic lifecycle, from initial discovery and preclinical evaluation to clinical development.
Therapeutic Immunology
Her career has focused on creating treatments for autoimmune diseases, inflammation, and cancer, including novel immuno-oncology therapeutics.
Scientific Innovation
As a co-inventor on numerous patents, she has consistently been involved in the discovery of novel genes and protein therapeutics.
Media Appearances
Jane has no verified media appearances
Work History
1-2008
Vice President, Research Immunology at ZymoGenetics Inc.
1-2005 - 1-2008
Senior Research Director Autoimmunity and Inflammation at ZymoGenetics Inc.
1-2004 - 1-2005
Research Director Autoimunity and Inflammation at ZymoGenetics Inc.
Education
1990 - 1994
Post-Doctoral Fellow from University of Washington - School of Medicine
1983 - 1989
Ph.D. from University of California, Berkeley
More Information
Social Presence :
Prographics :
Exp : 22
Location : Seattle, Washington, United States
Job Level : Senior
Designation : Vice President, Research Immunology at ZymoGenetics Inc.
